Xian-Bo Wang (Xianbo Wang)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 20

Top Topics

Hepatitis B Virus

Sentinel Lymph Node

Ejection Fraction

Top Venues

Hepatology research : the official journal of the Japan Society of Hepatology

Evidence-based complementary and alternative medicine : eCAM

This page only lists publications with an associated author ORCID identifier.

Publications

Fengna Yan, Bingbing Zhu, Ke Shi, Yi Zhang, Xuanwei Zeng, Qun Zhang, Zhiyun Yang, Xian-Bo Wang
Prognostic and therapeutic potential of imbalance between PD-1+CD8 and ICOS+Treg cells in advanced HBV-HCC. Cancer science 115 (8) (2024)
Fengna Yan, Bingbing Zhu, Ke Shi, Yi Zhang, Xuanwei Zeng, Qun Zhang, Zhiyun Yang, Xian-Bo Wang
Prognostic and therapeutic potential of imbalance between PD-1+CD8 and ICOS+Treg cells in advanced HBV-HCC. Cancer science 115 (8) (2024)
Hui Quan, Hao Yu, Xiao-Li Liu, Fei-Xiang Xiong, Yi-Xin Hou, Xian-Bo Wang, Zhi-Yun Yang, Yu-Yong Jiang
Development and validation of a prognostic model for 90-day survival in patients with alcohol-associated cirrhosis and acute decompensation. Hepatology research : the official journal of the Japan Society of Hepatology 54 (6) (2024)
Hui Quan, Hao Yu, Xiao-Li Liu, Fei-Xiang Xiong, Yi-Xin Hou, Xian-Bo Wang, Zhi-Yun Yang, Yu-Yong Jiang
Development and validation of a prognostic model for 90-day survival in patients with alcohol-associated cirrhosis and acute decompensation. Hepatology research : the official journal of the Japan Society of Hepatology (2024)
Fengna Yan, Bingbing Zhu, Ke Shi, Yi Zhang, Xuanwei Zeng, Qun Zhang, Zhiyun Yang, Xian-Bo Wang
Prognostic and therapeutic potential of imbalance between PD-1+CD8 and ICOS+Treg cells in advanced HBV-HCC. Cancer science 115 (8) (2024)
Ke Shi, Yufei Bi, Xiaojing Wang, Yanqiu Li, Xuanwei Zeng, Ying Feng, Xian-Bo Wang
Prognostic Value of High-Density Lipoprotein Cholesterol in Patients with Overt Hepatic Encephalopathy. Biomedicines 12 (8) (2024)
Hui Quan, Hao Yu, Xiao-Li Liu, Fei-Xiang Xiong, Yi-Xin Hou, Xian-Bo Wang, Zhi-Yun Yang, Yu-Yong Jiang
Development and validation of a prognostic model for 90-day survival in patients with alcohol-associated cirrhosis and acute decompensation. Hepatology research : the official journal of the Japan Society of Hepatology 54 (6) (2024)
Ke Shi, Yufei Bi, Xiaojing Wang, Yanqiu Li, Xuanwei Zeng, Ying Feng, Xian-Bo Wang
Prognostic Value of High-Density Lipoprotein Cholesterol in Patients with Overt Hepatic Encephalopathy. Biomedicines 12 (8) (2024)
Fengna Yan, Bingbing Zhu, Ke Shi, Yi Zhang, Xuanwei Zeng, Qun Zhang, Zhiyun Yang, Xian-Bo Wang
Prognostic and therapeutic potential of imbalance between PD-1+CD8 and ICOS+Treg cells in advanced HBV-HCC. Cancer science (2024)
Jie Hou, Ke Shi, Yao Liu, Jialiang Chen, Chongping Ran, Xian-Bo Wang
Effects of Traditional Chinese Medicine Adjuvant Therapy on the Survival of Patients with Primary Liver Cancer. Evidence-based complementary and alternative medicine : eCAM 2022 (2022)
Rui-Rui Wang, Hong-Qiu Gu, Ying-Ying Wei, Jin-Xiang Yang, Yi-Xin Hou, Hui-Min Liu, Zhi-Yun Yang, Xian-Bo Wang, Yu-Yong Jiang
Development and Validation of a Prognostic Model for One-year Survival of Cirrhosis Patients with First-ever Spontaneous Bacterial Peritonitis. Journal of clinical and translational hepatology 9 (5) (2021)
Ting-Ting Jiang, Xiao-Li Liu, Yu-Yong Jiang, Xian-Bo Wang, Zhi-Yun Yang
Minimal Hepatic Encephalopathy and Biejia-Ruangan Are Associated with First Hospital Readmission in Nonalcoholic Cirrhosis Patients. Evidence-based complementary and alternative medicine : eCAM 2021 (2021)
Xinhui Wang, Xiaoli Liu, Zhibo Dang, Zhi-Yun Yang, Yuyong Jiang, Xian-Bo Wang, Zhiyun Yan
Nucleos(t)ide Analogues for Reducing Hepatocellular Carcinoma in Chronic Hepatitis B Patients: A Systematic Review and Meta-Analysis. Gut and liver 14 (2) (2021)
Ke Shi, Yao Liu, Xiaojing Wang, Yuxin Li, Qun Zhang, Ying Hu, Chongping Ran, Yunyi Huang, Jie Hou, Xian-Bo Wang
Adjuvant Fuzheng Huayu Capsule Reduces the Incidence of Hepatocellular Carcinoma in Patients with Hepatitis B-Caused Cirrhosis. Evidence-based complementary and alternative medicine : eCAM 2020 (2020)
Jingyuan Liu, Yao Liu, Pan Xiang, Lin Pu, Haofeng Xiong, Chuansheng Li, Ming Zhang, Jianbo Tan, Yanli Xu, Rui Song, Meihua Song, Lin Wang, Wei Zhang, Bing Han, Li Yang, Xiaojing Wang, Guiqin Zhou, Ting Zhang, Ben Li, Yanbin Wang, Zhihai Chen, Xian-Bo Wang
Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage. Journal of translational medicine 18 (1) (2020)
Huimin Liu, Yuxin Li, Fangyuan Gao, Peipei Meng, Hao Yu, Tong Wu, Yang Zhou, Yu-Yong Jiang, Xian-Bo Wang
Serum Clusterin: A Potential Marker for Assessing the Clinical Severity and Short-Term Prognosis of Hepatitis B Virus-Related Acute-on-Chronic Liver Failure. Disease markers 2020 (2020)
Jing Liu, Yanhang Gao, Xian-Bo Wang, Zhiping Qian, Jinjun Chen, Yan Huang, Zhong Ji Meng, Xiaobo Lu, Guohong Deng, Feng Liu, Zhiguo Zhang, Hai Li, Xin Zheng
Culture-Positive Spontaneous Ascitic Infection in Patients with Acute Decompensated Cirrhosis: Multidrug-Resistant Pathogens and Antibiotic Strategies. Yonsei medical journal 61 (2) (2020)
Dong Jiang, Jianghua Wang, Xuesen Zhao, Yuxin Li, Qun Zhang, Chuan Song, Hui Zeng, Xian-Bo Wang
Entecavir resistance mutations rtL180M/T184L/M204V combined with rtA200V lead to tenofovir resistance. Liver international : official journal of the International Association for the Study of the Liver 40 (1) (2019)
Dong Jiang, Hui Zeng, Xian-Bo Wang
Response to comments on: Entecavir resistance mutations rtL180M/T184L/M204V combined with rtA200V lead to tenofovir resistance. Liver international : official journal of the International Association for the Study of the Liver 40 (3) (2019)
Fangyuan Gao, Xiaoshu Li, Gang Wan, Yuxin Li, Qun Zhang, Yao Liu, Huimin Liu, Hai Li, Xian-Bo Wang
Development and external validation of a prognostic nomogram for acute decompensation of chronic hepatitis B cirrhosis. BMC gastroenterology 18 (1) (2018)